Brief: Heidelberg Pharma Q1 Net Loss At EUR 7.2 Mln

Heidelberg Pharma AG

28/04/2022 06:18

April 28 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * Q1 NET LOSS -7.2 MILLION EUR
    * IN FIRST THREE MONTHS OF FISCAL YEAR 2022, GROUP GENERATED
SALES
REVENUE AND INCOME TOTALING EUR 0.8 MILLION (PREVIOUS YEAR: EUR
0.5 MILLION)
    * OUTLOOK 2022: SALES REVENUES AND OTHER INCOME FOR
HEIDELBERG
PHARMA GROUP BETWEEN EUR 7.5 MILLION AND EUR 9.5 MILLION IN 2022
FISCAL YEAR (2021: EUR 2.3 MILLION)
    * EARNINGS BEFORE INTEREST AND TAXES (EBIT) IN 2022 FISCAL
YEAR
ARE EXPECTED TO BE BETWEEN EUR -32.5 MILLION AND EUR -36.5
MILLION (2021: EUR -25.6 MILLION)

Source text for Eikon:  ID:nEQ4hGr68a 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))